Huang JQ et al. |
Do patients with non-ulcer dyspepsia respond differently to Helicobacter pylori eradication treatments from those with peptic ulcer disease? A systematic review. |
2005 |
World J. Gastroenterol. |
pmid:15884111
|
Gumurdulu Y et al. |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey. |
2004 |
World J. Gastroenterol. |
pmid:14991935
|
Guo CY et al. |
Clinical evaluation of four one-week triple therapy regimens in eradicating Helicobacter pylori infection. |
2004 |
World J. Gastroenterol. |
pmid:14991953
|
Mirbagheri SA et al. |
Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial. |
2006 |
World J. Gastroenterol. |
pmid:16937475
|
Attaran B et al. |
Effect of biofilm formation by clinical isolates of on the efflux-mediated resistance to commonly used antibiotics. |
2017 |
World J. Gastroenterol. |
pmid:28275296
|
Ching SS et al. |
Treatment of Helicobacter pylori in surgical practice: a randomised trial of triple versus quadruple therapy in a rural district general hospital. |
2008 |
World J. Gastroenterol. |
pmid:18609709
|
Buzás GM and Józan J |
First-line eradication of H pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2004. |
2006 |
World J. Gastroenterol. |
pmid:16981260
|
Babic Z et al. |
Increased activity of Pgp multidrug transporter in patients with Helicobacter pylori infection. |
2005 |
World J. Gastroenterol. |
pmid:15884110
|
Wang B et al. |
Standard triple therapy for Helicobacter pylori infection in China: a meta-analysis. |
2014 |
World J. Gastroenterol. |
pmid:25356059
|
Ji F et al. |
Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial. |
2006 |
World J. Gastroenterol. |
pmid:16586550
|
Zhou Q et al. |
Drug utilization of clarithromycin for gastrointestinal disease treatment. |
2008 |
World J. Gastroenterol. |
pmid:18932287
|
Sereni G et al. |
Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection. |
2012 |
World J. Gastroenterol. |
pmid:22969227
|
Isomoto H et al. |
Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin. |
2005 |
World J. Gastroenterol. |
pmid:15786539
|
Wang HH et al. |
One-year follow-up study of Helicobacter pylori eradication rate with 13C-urea breath test after 3-d and 7-d rabeprazole-based triple therapy. |
2005 |
World J. Gastroenterol. |
pmid:15786549
|
Gao XZ et al. |
Standard triple, bismuth pectin quadruple and sequential therapies for Helicobacter pylori eradication. |
2010 |
World J. Gastroenterol. |
pmid:20818821
|
Pan W et al. |
Effects of clopidogrel and clarithromycin on the disposition of sibutramine and its active metabolites M1 and M2 in relation to CYP2B6*6 polymorphism. |
2013 |
Xenobiotica |
pmid:22830954
|
Kanayama N et al. |
Drug-drug interactions in the metabolism of imidafenacin: role of the human cytochrome P450 enzymes and UDP-glucuronic acid transferases, and potential of imidafenacin to inhibit human cytochrome P450 enzymes. |
2007 |
Xenobiotica |
pmid:17484517
|
Burt HJ et al. |
IC50-based approaches as an alternative method for assessment of time-dependent inhibition of CYP3A4. |
2010 |
Xenobiotica |
pmid:20230210
|
Kubo JI et al. |
Pharmacokinetic evaluation of high pulmonary disposition of clarithromycin after systemic administration. |
2002 |
Xenobiotica |
pmid:12419017
|
Yamamoto T et al. |
Prediction of oral clearance from in vitro metabolic data using recombinant CYPs: comparison among well-stirred, parallel-tube, distributed and dispersion models. |
2005 |
Xenobiotica |
pmid:16192112
|